Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

Autor: Miguel Gil-Gil, José A. García-Sáenz, E Dalmau Portulas, Elena García-Martínez, Nuria Ribelles, A. Santaballa Bertran, E. Martínez de Dueñas, I Alvarez-Lopez, Susana Bezares

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Clinical & Translational Oncology

PurposeHormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on anti-estrogen hormo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63a263cb82f360402dddafab187eefb
http://hdl.handle.net/2445/174389

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

Autor: Roberto Torres, P López-Álvarez, Carlos Sampaio, Carlos Barrios, E Villar, Eva Carrasco, A. Lluch, L Pérez-Michel, J.G.M. Segalla, S. Reyes, JA Garcia-Saenz, J. Cárdenas, Maria Jose Godes, M. Ramos, J Castellanos, A. Ruiz, M. J. Escudero, E Martínez de Dueñas, Lourdes Calvo, J Moncayo, J. M. Baena, Manuel Ruiz-Borrego, J. Vinholes, L Torrecillas, Susana Bezares, M. Martin, Henry L. Gomez, Agust Barnadas, M. A. Seguí, Antonio Llombart, Gilberto Luiz da Silva Amorim, J. Bines, Álvaro Rodríguez-Lescure, M Rodríguez de la Borbolla, Antonio Antón, J de la Haba, B Cardemil, E Garcia

Publikováno v: Cancer Research. 79:GS2-04

Background: Triple negative breast cancers (TNBC) have a greater risk of relapse than non-TNBC. New therapeutic approaches are needed for these patients (pts). CIBOMA/2004-01_GEICAM/2003-11 is a multinational, randomized phase III trial exploring adj

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0aebf64b3256301578ee24865dcc030
https://doi.org/10.1158/1538-7445.sabcs18-gs2-04

SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

Autor: M. Bellet Ezquerra, S. Antolin Novoa, Mafalda Oliveira, E. Martínez de Dueñas, S. López-Tarruella Cobo, M. A. Segui Palmer, L. de la Cruz Merino, J. Gavila Gregori, I. Álvarez López, J. I. Chacón López-Muñiz

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Clinical & Translational Oncology

Recurrència loco-regional; Càncer de mama; Pautes Recurrencia loco-regional; Cáncer de mama; Pautas Loco-regional recurrence; Breast cancer; Guidelines Although the metastasic breast cancer is still an incurable disease, recent advances have incre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99ab8f97d50d5114bc5b368698614ee
http://hdl.handle.net/10261/212722

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain

Autor: Noelia Martínez-Jañez, E. Martínez de Dueñas, F. Carabantes, L. Murillo, José A. García-Sáenz, R. Fonseca, Joaquín Gavilá, Eva Ciruelos, Maria Vidal, Yolanda Fernández, A. Beliera

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Background Everolimus with exemestane has shown promising activity in patients with hormone-receptor (HR)-positive HER2-negative endocrine-resistant advanced breast cancer. It is necessary, therefore, to characterize the safety profile of this new co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79938308c818a703dcebff2328f73ae3
https://pubmed.ncbi.nlm.nih.gov/29116433